This webinar focuses on key challenges in infection management in the ICU. It will explore three major controversies—clinical metagenomic diagnostics, selective digestive tract decontamination, and immunomodulation in sepsis—highlighting how emerging evidence is reshaping clinical practice and advancing more personalised care for critically ill patients.
Chair: Louis Kreitmann, GSTT, London
Presentations:
- Clinical metagenomics for diagnosing severe infections - Chaz Langelier, USSF, San Francisco, USA
-
Selective digestive tract decontamination - Speaker TBC
-
Immunomodulation in sepsis - Manu Shankar-Hari, King's College, London, UK
Learning Objectives
- Critically assess the role of clinical metagenomics in ICU diagnostics, including its advantages, limitations, and impact on antimicrobial decision-making.
- Evaluate the benefits and risks of selective digestive tract decontamination, with a focus on clinical outcomes and antimicrobial resistance.
- Analyse the rationale and evidence for immunomodulatory therapies in sepsis, including their role in personalised critical care management.
Speakers
